Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;101:455-464
Published online before print July 12, 2007, doi: 10.1161/CIRCRESAHA.107.151852
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
101/5/455    most recent
CIRCRESAHA.107.151852v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lavrentyev, E. N.
Right arrow Articles by Malik, K. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lavrentyev, E. N.
Right arrow Articles by Malik, K. U.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Cell signalling/signal transduction
Right arrow Other diabetes
Right arrow Other Vascular biology
Right arrow Other Research
(Circulation Research. 2007;101:455.)
© 2007 American Heart Association, Inc.


Molecular Medicine

Mechanism of High Glucose–Induced Angiotensin II Production in Rat Vascular Smooth Muscle Cells

Eduard N. Lavrentyev, Anne M. Estes, Kafait U. Malik

From the Department of Pharmacology, College of Medicine, University of Tennessee Health Science Center, Memphis.

Correspondence to Kafait U. Malik, PhD, DSc, Professor of Pharmacology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163. E-mail kmalik{at}utmem.edu

Angiotensin II (Ang II), a circulating hormone that can be synthesized locally in the vasculature, has been implicated in diabetes-associated vascular complications. This study was conducted to determine whether high glucose (HG) ({approx}23.1 mmol/L), a diabetic-like condition, stimulates Ang II generation and the underlying mechanism of its production in rat vascular smooth muscle cells. The contribution of various enzymes involved in Ang II generation was investigated by silencing their expression with small interfering RNA in cells exposed to normal glucose ({approx}4.1 mmol/L) and HG. Angiotensin I (Ang I) was generated from angiotensinogen by cathepsin D in the presence of normal glucose or HG. Although HG did not affect the rate of angiotensinogen conversion, it decreased expression of angiotensin-converting enzyme (ACE), downregulated ACE-dependent Ang II generation, and upregulated rat vascular chymase–dependent Ang II generation. The ACE inhibitor captopril reduced Ang II levels in the media by 90% in the presence of normal glucose and 19% in HG, whereas rat vascular chymase silencing reduced Ang II production in cells exposed to HG but not normal glucose. The glucose transporter inhibitor cytochalasin B, the aldose reductase inhibitor alrestatin, and the advanced glycation end product formation inhibitor aminoguanidine attenuated HG-induced Ang II generation. HG caused a transient increase in extracellular signal-regulated kinase (ERK)1/2 phosphorylation, and ERK1/2 inhibitors reduced Ang II accumulation by HG. These data suggest that polyol pathway metabolites and AGE can stimulate rat vascular chymase activity via ERK1/2 activation and increase Ang II production. In addition, decreased Ang II degradation, which, in part, could be attributable to a decrease in angiotensin-converting enzyme 2 expression observed in HG, contributes to increased accumulation of Ang II in vascular smooth muscle cells by HG.


Key Words: ACE • vascular chymase • angiotensin • VSMC • high glucose




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. N. Lavrentyev and K. U. Malik
High glucose-induced Nox1-derived superoxides downregulate PKC-{beta}II, which subsequently decreases ACE2 expression and ANG(1-7) formation in rat VSMCs
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H106 - H118.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. P. Singh, B. Le, R. Khode, K. M. Baker, and R. Kumar
Intracellular Angiotensin II Production in Diabetic Rats Is Correlated With Cardiomyocyte Apoptosis, Oxidative Stress, and Cardiac Fibrosis
Diabetes, December 1, 2008; 57(12): 3297 - 3306.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Descorbeth and M. B. Anand-Srivastava
High glucose increases the expression of Gq/11{alpha} and PLC-{beta} proteins and associated signaling in vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2135 - H2142.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Spinetti, N. Kraenkel, C. Emanueli, and P. Madeddu
Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies
Cardiovasc Res, May 1, 2008; 78(2): 265 - 273.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. P. Singh, K. M. Baker, and R. Kumar
Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1675 - H1684.
[Abstract] [Full Text] [PDF]